On May 23, 2018, we published revised versions of our Privacy Policy and User Agreements. Please read these updated terms and take some time to understand them. Your use of our services is subject to these revised terms.
Yes, I Agree.
TuesdayOct 31, 2023 2:08 pm

QualityStocksNewsBreaks – Scinai Immunotherapeutics Ltd. (NASDAQ: SCNI) Releases Q3 2023 Financial Report, Reports Possible Adjustment of Facility Terms by EIB

Scinai Immunotherapeutics (NASDAQ: SCNI), a biopharmaceutical company focused on developing, manufacturing and commercializing innovative inflammation and immunology (“I&I”) biological products primarily for the treatment of autoimmune and infectious diseases, is reporting on its financial results for the third quarter ended Sept. 30, 2023; the report also included key business updates. Financial numbers to note in the report include R&D expenses of $1.13 million compared to $1.19 million for the same quarter in 2022; marketing, general and administrative expenses for the quarter totaled $0.97 million compared to $0.96 million for the three months ended Sept. 30, 2022; total operating expenses for the quarter came in at…

Continue Reading

TuesdayOct 31, 2023 2:00 pm

QualityStocksNewsBreaks – HeartBeam Inc. (NASDAQ: BEAT) to Host Third Quarter 2023 Results Conference Call

HeartBeam (NASDAQ: BEAT), a cardiac technology company that has developed the first and only credit card-size 3D-vector electrocardiogram (“VECG”) platform for patient use at home, announced that it will hold a conference call on Tuesday, Nov. 14, 2023, at 4:30 p.m. Eastern Time to discuss its results for the third quarter ended Sept. 30, 2023. The company will also review recent announcements, ongoing initiatives and anticipated 2024 milestones. HeartBeam CEO and Founder Branislav Vajdic, PhD, President Robert Eno and CFO Richard Brounstein will host the call, followed by a question-and-answer period. Accompanying the conference call will be a presentation, which…

Continue Reading

TuesdayOct 31, 2023 1:51 pm

QualityStocksNewsBreaks – Eloro Resources Ltd. (TSX.V: ELO) (OTCQX: ELRRF) (FSE: P2QM) Reports on Voting at Annual Meeting

Eloro Resources (TSX.V: ELO) (OTCQX: ELRRF) (FSE: P2QM), an exploration and mine-development company with a portfolio of gold and base-metal properties in Bolivia, Peru and Quebec, is reporting on the voting held during its annual shareholder meeting. The meeting was held virtually on Oct. 30, 2023. According to the report, a total of 29,893,834 common shares representing 38.90% of the company`s issued and outstanding common shares were voted in connection with the meeting. The shareholders attending the meeting voted in favor of the six director nominees, including Thomas Larsen, Francis Sauve, Alexander Horvath, Dusan Berka, Richard Stone and Pablo Ordoñez;…

Continue Reading

TuesdayOct 31, 2023 1:41 pm

QualityStocksNewsBreaks – Appia Rare Earths & Uranium Corp. (CSE: API) (OTCQX: APAAF) (FSE: A0I0) Announces Exceptional Assay Drill Results from Its PCH Ionic Clay Project

Appia (CSE: API) (OTCQX: APAAF) (FSE: A0I0) today announced a groundbreaking discovery of an extraordinary high-grade total rare earth oxides (“TREO”) intersection extending the known area of target IV at its PCH Ionic Clay Project located within the Goiás state of Brazil. According to the announcement, hole PCH-RC-063 contains unique high grades and depth of mineralization, spanning an impressive 24 metres from top to bottom, and remains open at depth. “These drill results are the highest TREO grades detected on the PCH property to date,” said Appia’s CEO Tom Drivas. “The data released today reveals an unprecedent concentration of TREO…

Continue Reading

TuesdayOct 31, 2023 12:05 pm

QualityStocksNewsBreaks – PaxMedica Inc. (NASDAQ: PXMD) Acquires Research Assets to Accelerate PAX-101 NDA Submission

PaxMedica (NASDAQ: PXMD), a pioneering biopharmaceutical company specializing in cutting-edge treatments for neurological disorders, today announced the successful acquisition of certain suramin research assets from Rediscovery Life Sciences (“RLS”). The assets were previously dedicated to the study of suramin’s potential efficacy in treating acute kidney injury resulting from chronic kidney disease. According to the announcement, the newly acquired data from RLS will play a crucial role in bolstering PaxMedica’s ongoing efforts to support the submission for the approval of PAX-101, specifically for the treatment of African sleeping sickness caused by the Trypanosoma brucei rhodesiense parasite. “Acquiring the research assets from…

Continue Reading

TuesdayOct 31, 2023 12:00 pm

Exploring the Future of Finance at the New Orleans Investment Conference 2023

Investors, policymakers, enthusiasts, technologists, decision-makers, and business owners are invited to attend the New Orleans Investment Conference to be held in New Orleans, Louisiana, November 1-4, 2023. The 2023 edition of this iconic event is committed to paving the way to real investment insights and financial wisdom in a fast-changing economic landscape. Having a rich history of successful investment symposiums, the New Orleans Investment Conference has consistently brought together some of the brightest minds in finance, politics, and economics. The conference will feature a lineup of world-renowned speakers who will share valuable investment strategies to unlock the secrets of financial…

Continue Reading

TuesdayOct 31, 2023 10:45 am

QualityStocksNewsBreaks – GEMXX Corporation (GEMZ) Reports on Key Milestones for 2023, Provides Update on Targets Moving Forward

GEMXX (OTC: GEMZ), a leader in the ammolite gemstone mine-to-market segment and a partner in Canadian gold-exploration company Crazy Horse Mining Inc. (“CHMI”), has released an update on corporate highlights and milestones for the company. According to the announcement, the report is provided for new and existing investors as the company prepares to release its quarter-end financial report. Highlights for this year include the successful completion of the third and final clean-out and recording of gold production at the Snow Creek Mine site for the 2023 mining test season; the partnership with Aurora Geosciences to complete S-K 1300 technical reports…

Continue Reading

TuesdayOct 31, 2023 10:30 am

Freight Technologies Inc. (NASDAQ: FRGT) Taking Part in the Trucking Industry’s Ongoing Paradigm Shift with Its Fr8App Platform

Lexaria, a global innovator in drug delivery platforms, just announced an exclusive license to SulfoSyn Limited to use its patented DehydraTECH(TM) technology Lexaria will also perform specific DehydraTECH-related manufacturing operations on SulfoSyn’s behalf for an initial term of 2 years The license agreement adds to Lexaria’s growing list, which, as of the last two years, includes BevNology LLC, Premier Wellness Science Co. Ltd., and Dehydr8, LLC, among others It highlights the superiority of Lexaria’s technology, as further compounded by the 37 patents granted so far Lexaria Bioscience (NASDAQ: LEXX), a global innovator in drug delivery platforms, just announced its latest…

Continue Reading

TuesdayOct 31, 2023 9:00 am

Lexaria Bioscience Corp. (NASDAQ: LEXX) Grows List of Licensed Partners Following Exclusive Collaboration and License Agreement with SulfoSyn

Lexaria, a global innovator in drug delivery platforms, just announced an exclusive license to SulfoSyn Limited to use its patented DehydraTECH(TM) technology Lexaria will also perform specific DehydraTECH-related manufacturing operations on SulfoSyn’s behalf for an initial term of 2 years The license agreement adds to Lexaria’s growing list, which, as of the last two years, includes BevNology LLC, Premier Wellness Science Co. Ltd., and Dehydr8, LLC, among others It highlights the superiority of Lexaria’s technology, as further compounded by the 37 patents granted so far Lexaria Bioscience (NASDAQ: LEXX), a global innovator in drug delivery platforms, just announced its latest…

Continue Reading

MondayOct 30, 2023 3:05 pm

QualityStocksNewsBreaks – Electronic Servitor Publication Network Inc. (XESP) Announces Participation at Emerging Growth Conference

Electronic Servitor Publication Network (OTCQB: XESP), a digital engagement company and market disruptor, today announced that it has been invited to present at the Emerging Growth Conference on Nov. 1, 2023. The live, interactive online event offers existing shareholders and the investment community an opportunity to interact with the company’s president and CEO Peter Hager. Hager will provide a presentation beginning at 11:25 a.m. ET on Wednesday, Nov. 1, and may subsequently open the floor for questions. Interested parties should visit https://ibn.fm/Ir3ZD to register for and access the webcast. An archived webcast will be made available on EmergingGrowth.com and on…

Continue Reading

Market Basics

New to the micro-cap markets?Get answers to your questions about investing in Small-Cap / Micro-Cap Stocks and learn how to protect yourself.

The Basics

Newsletter Publishers

Have an up and coming newsletter and want to be included in our coverage list? Looking to get more coverage and grow subscriptions? Register for coverage.

Register

Public Companies

Are you a Small-Cap / Micro-Cap company looking for coverage? We'd love to hear from you. Fill out our quick contact form or send us a text.

Get Covered